Market Tracker

02/23 5:15pm ET

OPKO Health Inc (NASDAQ:OPK)

3.80
Delayed Data
As of Feb 23
 +0.18 / +4.97%
Today’s Change
3.55
Today|||52-Week Range
8.69
-22.45%
Year-to-Date
Weekly CEO Buys Highlight
Feb 19 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close3.62
Today’s open3.66
Day’s range3.65 - 3.83
Volume3,887,026
Average volume (3 months)4,531,832
Market cap$2.1B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)-422.48%
Earnings growth (next 5 years)+70.80%
Revenue growth (last year)+148.44%
P/E ratioNM
Price/Sales4.19
Price/Book1.01

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+0.80+1.78%
CLVSClovis Oncology Inc-3.04-5.08%
PBYIPuma Biotechnology I...+2.10+3.17%
MNKMallinckrodt Plc+0.24+1.51%
Data as of 4:02pm ET, 02/23/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$1.2B
Annual profit (last year)-$25.1M
Net profit margin-2.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer &
Senior Vice President
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts